Literature DB >> 25879352

The role of cigarette smoking and alcohol consumption in the differentiation of oral squamous cell carcinoma for the males in China.

Xinhua Wang, Ji Xu, Lijuan Wang, Chao Liu, Huiming Wang1.   

Abstract

BACKGROUND: Oral squamous cell carcinoma (OSCC) is one of the most common cancers in the world and two-thirds of the OSCC occur in developing countries. Male and female have different smoking and drinking habit. However, there is little gender-specific risk study between OSCC and the habit of drinking and smoking in China. AIMS: The aim of this study was to evaluate the effects of smoking and alcohol consumption in the differentiation grade of OSCC for the male in China. PATIENTS AND METHODS: Review cases of male patients who suffered from OSCC tylectomy and were pathologically confirmed the diagnosis of OSCC. Data from 210 cases, related to patient, smoking, and alcohol drinking, were collected and analyzed using multivariate conditional logistic regression models.
RESULTS: Cigarette smoking and alcohol consumption were strongly associated with differentiation of oral cancer (P = 0.013 and 0.005, respectively). The adjusted odds ratios (ORs) for smoker were 1.45 (95% confidence interval (CI) = 0.145-4.19). The ORs for drinkers were 0.56 (95% CI = 0.19-1.58). The risk of the two habits in the development of oral cancer appeared to be significant increase. Increased risk of low oral cancer differentiation was associated with increased amount of alcohol consumed.
CONCLUSIONS: Heavy and long-term smoking and drinking habit might pronouncedly increase the risk of triggering OSCC. Tobacco and alcohol consumption seems to play a role in the differentiation characteristics of the tumor.

Entities:  

Mesh:

Year:  2015        PMID: 25879352     DOI: 10.4103/0973-1482.137981

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  8 in total

1.  Assessment of Histopathological Grade and Ki-67 Expression in Tobacco and Non-tobacco Habitual Buccal Mucosa Cancer.

Authors:  Ramasamy Padma; Sivapatham Sundaresan; Amitkumar Kalaivani; Ramamurthy Thilagavathi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-06

2.  Buccal Mucosa Carcinoma: A Comparative Relative Risk Analysis between Tobacco and Non Tobacco Users.

Authors:  Ramasamy Padma; Amitkumar Kalaivani; Sathish Paulraj; Sivapatham Sundaresan
Journal:  J Clin Diagn Res       Date:  2017-06-01

3.  Impact of the anatomical location, alcoholism and smoking on the prevalence of advanced oral cancer in Brazil.

Authors:  N-V-F Bezerra; K-L-F Leite; M-M-D de Medeiros; M-L Martins; A-M-R Cardoso; P-M Alves; W-W-N Padilha; Y-W Cavalcanti
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-05-01

4.  Differences in modifiable factors of oral squamous cell carcinoma in the upper and lower of oral fissure.

Authors:  Lingjun Yan; Fa Chen; Fengqiong Liu; Yu Qiu; Jing Wang; Junfeng Wu; Xiaodan Bao; Zhijian Hu; Xiane Peng; Xu Lin; Lin Cai; Lisong Lin; Baochang He
Journal:  Oncotarget       Date:  2017-08-24

Review 5.  mTOR Signalling in Head and Neck Cancer: Heads Up.

Authors:  Fiona H Tan; Yuchen Bai; Pierre Saintigny; Charbel Darido
Journal:  Cells       Date:  2019-04-09       Impact factor: 6.600

6.  A genetic programming approach to oral cancer prognosis.

Authors:  Mei Sze Tan; Jing Wei Tan; Siow-Wee Chang; Hwa Jen Yap; Sameem Abdul Kareem; Rosnah Binti Zain
Journal:  PeerJ       Date:  2016-09-21       Impact factor: 2.984

Review 7.  Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis.

Authors:  Amr Bugshan; Imran Farooq
Journal:  F1000Res       Date:  2020-04-02

8.  Droplet Digital PCR Analysis of Liquid Biopsy Samples Unveils the Diagnostic Role of hsa-miR-133a-3p and hsa-miR-375-3p in Oral Cancer.

Authors:  Salvatore Crimi; Luca Falzone; Giuseppe Gattuso; Caterina Maria Grillo; Saverio Candido; Alberto Bianchi; Massimo Libra
Journal:  Biology (Basel)       Date:  2020-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.